Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital… EP News Bureau Jul 30, 2020 By the end of March 2020, Semglee was approved in 60 countries and launched in several countries including the EU, Australia and…
Biocon Biologics and Voluntis collaborate on digital therapeutics for insulins EP News Bureau Jul 21, 2020 Insulia is the first digital therapeutic with regulatory clearance to provide automated titration recommendations for all types of…
